Chitogenx Stock Price, News & Analysis
Company Description
Chitogenx (OTC Link: CHNXF) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $424.0K.
CHNXF stock has declined 39.2% over the past year. Shares last traded at $0.0076.
This page provides a comprehensive overview of CHNXF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Chitogenx (CHNXF) stock last traded at $0.0076. Over the past 12 months, the stock has lost 39.2%. At a market capitalization of $424.0K, CHNXF is classified as a micro-cap stock with approximately 83.1M shares outstanding.
Latest News
Chitogenx has 1 recent news article. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. View all CHNXF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
CHNXF Company Profile & Sector Positioning
Chitogenx (CHNXF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing CHNXF often look at related companies in the same sector, including Viracta Therapeutics Inc (VIRX), SYBLEU Inc (SYBE), Therapeutic Solutions Intl Inc (TSOI), Theralink Technologies Inc (THER), and Bio-Path Hldgs Inc (BPTH). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CHNXF's relative position within its industry.